Inhibition of dengue virus production and cytokine/chemokine expression by ribavirin and compound A
- 1 December 2015
- journal article
- research article
- Published by Elsevier in Antiviral Research
- Vol. 124, 83-92
Abstract
No abstract availableKeywords
Funding Information
- Thailand Research Fund (TRF)
- Mahidol University
This publication has 48 references indexed in Scilit:
- Cytokine Expression Profile of Dengue Patients at Different Phases of IllnessPLOS ONE, 2012
- Cellular and Cytokine Correlates of Severe Dengue InfectionPLOS ONE, 2012
- Kinetics of Viremia and NS1 Antigenemia Are Shaped by Immune Status and Virus Serotype in Adults with DenguePLOS Neglected Tropical Diseases, 2011
- Modulation of Cytokine and Cytokine Receptor/Antagonist by Treatment with Doxycycline and Tetracycline in Patients with Dengue FeverJournal of Immunology Research, 2011
- Dengue, Urbanization and Globalization: The Unholy Trinity of the 21st CenturyTropical Medicine and Health, 2011
- Combination of α-glucosidase inhibitor and ribavirin for the treatment of dengue virus infection in vitro and in vivoAntiviral Research, 2011
- Therapeutic and Adverse Effects of a Non-Steroidal Glucocorticoid Receptor Ligand in a Mouse Model of Multiple SclerosisPLOS ONE, 2009
- NF-κB-dependent synergistic regulation of CXCL10 gene expression by IL-1β and IFN-γ in human intestinal epithelial cell linesInternational Journal of Colorectal Disease, 2007
- DengueThe Lancet, 2007
- Dengue Viremia Titer, Antibody Response Pattern, and Virus Serotype Correlate with Disease SeverityThe Journal of Infectious Diseases, 2000